ODDB.org: Open Drug Database

Teva Pharma AG - Irinotecan-Teva liquid 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	59217	Sequence	01
Product name	Irinotecan-Teva liquid 40 mg/2 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01CE02	ATC-Description
Introduction of Sequence	06.05.2009

Composition

irinotecani hydrochloridum trihydricum 40 mg, sorbitolum 90 mg, acidum (S)-lacticum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 0.173 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	40mg / 2ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	40 mg

Inactive agents	Dose



Sorbitol	90mg / 2ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005		38.11	57.85	A	SL	No

2025	©ywesee GmbH